Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)

Balmiki Ray; Bryan Maloney; Kumar Sambamurti; Hanuma K. Karnati; Peter T. Nelson; Nigel H. Greig; Debomoy K. Lahiri

doi:10.1038/s41398-020-0757-2

Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)

Balmiki Ray, Bryan Maloney, Kumar Sambamurti, Hanuma K. Karnati, Peter T. Nelson, Nigel H. Greig, Debomoy K. Lahiri

Research output: Contribution to journal › Comment/debate

Abstract

The original article contained few errors: Hanuma K. Karnati’s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article.

Original language	English
Article number	81
Journal	Translational Psychiatry
Volume	10
Issue number	1
DOIs	https://doi.org/10.1038/s41398-020-0757-2
State	Published - Dec 1 2020

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

Funding

Funders	Funder number
National Institute on Aging	P30AG028383
National Institute on Aging

ASJC Scopus subject areas

Psychiatry and Mental health
Cellular and Molecular Neuroscience
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41398-020-0757-2

Cite this

Ray, B., Maloney, B., Sambamurti, K., Karnati, H. K., Nelson, P. T., Greig, N. H., & Lahiri, D. K. (2020). Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x). Translational Psychiatry, 10(1), Article 81. https://doi.org/10.1038/s41398-020-0757-2

@article{c5d30ac3379146f284d99c978551b103,

title = "Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer{\textquoteright}s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)",

abstract = "The original article contained few errors: Hanuma K. Karnati{\textquoteright}s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article.",

author = "Balmiki Ray and Bryan Maloney and Kumar Sambamurti and Karnati, {Hanuma K.} and Nelson, {Peter T.} and Greig, {Nigel H.} and Lahiri, {Debomoy K.}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41398-020-0757-2",

language = "English",

volume = "10",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)

AU - Ray, Balmiki

AU - Maloney, Bryan

AU - Sambamurti, Kumar

AU - Karnati, Hanuma K.

AU - Nelson, Peter T.

AU - Greig, Nigel H.

AU - Lahiri, Debomoy K.

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The original article contained few errors: Hanuma K. Karnati’s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article.

AB - The original article contained few errors: Hanuma K. Karnati’s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article.

UR - http://www.scopus.com/inward/record.url?scp=85080858071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080858071&partnerID=8YFLogxK

U2 - 10.1038/s41398-020-0757-2

DO - 10.1038/s41398-020-0757-2

M3 - Comment/debate

C2 - 32123156

AN - SCOPUS:85080858071

SN - 2158-3188

VL - 10

JO - Translational Psychiatry

JF - Translational Psychiatry

IS - 1

M1 - 81

ER -

Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease (Translational Psychiatry, (2020), 10, 1, (47), 10.1038/s41398-020-0709-x)

Abstract

Bibliographical note

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this